EP 3346912 A4 20190821 - METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR CONDITIONS ASSOCIATED WITH CEREBRO-CRANIOFACIAL HEALTH
Title (en)
METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR CONDITIONS ASSOCIATED WITH CEREBRO-CRANIOFACIAL HEALTH
Title (de)
VERFAHREN UND SYSTEM FÜR MIKROBIOM-DERIVIERTE DIAGNOSTIKA UND THERAPEUTIKA FÜR ERKRANKUNGEN IM ZUSAMMENHANG MIT ZEREBRO-KRANIOFAZIALER GESUNDHEIT
Title (fr)
PROCÉDÉ ET SYSTÈME POUR DES DIAGNOSTICS DÉRIVÉS DU MICROBIOME ET AGENTS THÉRAPEUTIQUES POUR DES AFFECTIONS ASSOCIÉES À LA SANTÉ CÉRÉBRO-CARNIOFACIALE
Publication
Application
Priority
- US 201562216016 P 20150909
- US 201562216028 P 20150909
- US 201562215939 P 20150909
- US 201562216035 P 20150909
- US 201562216042 P 20150909
- US 2016051155 W 20160909
Abstract (en)
[origin: WO2017044885A1] Methods, compositions, and systems are provided for detecting one or more a cognition health issues by characterizing the microbiome of an individual, monitoring such effects, and/or determining, displaying, or promoting a therapy for the cognition health issue. Methods, compositions, and systems are also provided for generating and comparing microbiome composition and/or functional diversity datasets. Methods, compositions, and systems are also provided for generating a characterization model and/or therapy model for insomnia issues, light sleep issues, headache issues, sinusitis issues, and poor concentration issues.
IPC 8 full level
G16H 50/20 (2018.01); A61B 5/00 (2006.01); C12Q 1/68 (2018.01); G16B 20/00 (2019.01); G16B 20/20 (2019.01); G16B 30/10 (2019.01); G16B 40/20 (2019.01); G16H 50/70 (2018.01)
CPC (source: EP US)
C12Q 1/689 (2013.01 - EP); G16B 20/00 (2019.01 - EP); G16B 20/20 (2019.01 - EP US); G16B 30/10 (2019.01 - EP US); G16B 40/20 (2019.01 - EP US); G16H 20/70 (2017.12 - EP); G16H 50/20 (2017.12 - EP); G16H 50/50 (2017.12 - EP); C12Q 2600/106 (2013.01 - EP); C12Q 2600/158 (2013.01 - EP); G16B 30/00 (2019.01 - EP); G16B 40/00 (2019.01 - EP); Y02A 90/10 (2017.12 - EP)
Citation (search report)
- [X] WO 2014179965 A1 20141113 - PROCTER & GAMBLE [US], et al
- [XYI] US 2014301995 A1 20141009 - MAYRA-MAKINEN ANNIKA [FI], et al
- [A] US 2015211078 A1 20150730 - APTE ZACHARY [US], et al
- [Y] WO 2013176774 A1 20131128 - UNIV ARIZONA [US]
- [YP] WO 2016065075 A1 20160428 - UBIOME INC [US]
- [YP] US 2016232280 A1 20160811 - APTE ZACHARY [US], et al
- See references of WO 2017044885A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2017044885 A1 20170316; AU 2016321333 A1 20180426; CA 3006044 A1 20170316; CN 108348167 A 20180731; CN 108348167 B 20220603; EP 3346912 A1 20180718; EP 3346912 A4 20190821
DOCDB simple family (application)
US 2016051155 W 20160909; AU 2016321333 A 20160909; CA 3006044 A 20160909; CN 201680065085 A 20160909; EP 16845218 A 20160909